Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris
Public ClinicalTrials.gov record NCT02616614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Clindamycin 1.2% and Benzoyl Peroxide 3.75% Gel to Onexton® Gel in Subjects With Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl peroxide 3.75% gel. This study is designed to evaluate the safety and efficacy of this formulation in subjects with Acne Vulgaris
Study identification
- NCT ID
- NCT02616614
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 862 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2015 (Type not available)
- Primary completion
- Oct 2015 (Actual)
- Completion
- Nov 2015 (Actual)
- Last update posted
- May 27, 2020
2015
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alliance Dermatology | Phoenix | Arizona | 85032 | — |
| Estudy | Chula Vista | California | 91911 | — |
| Estudy | La Mesa | California | 91942 | — |
| Tampa Bay Medical Research | Clearwater | Florida | 33761 | — |
| AMB Research Center | Miami | Florida | 33144 | — |
| Meridian Clinical Research | Savannah | Georgia | 31406 | — |
| Heartland Research Assoc | Augusta | Kansas | 67010 | — |
| Heartland Research Assoc | Wichita | Kansas | 67207 | — |
| Sundance Clinical Research | St Louis | Missouri | 63141 | — |
| Meridian Clinical Research | Norfolk | Nebraska | 68701 | — |
| Meridian Clinical Research | Omaha | Nebraska | 68134 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Sterling Research Group | Cincinnati | Ohio | 45246 | — |
| Discover Research | Beaumont | Texas | 77701 | — |
| DiscoverResearch Inc | Bryan | Texas | 77802 | — |
| Reseacr Across America | Dallas | Texas | 75234 | — |
| Clinical Research Assoc. of Tidewater | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02616614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02616614 live on ClinicalTrials.gov.